A2780
Resource Report
Resource Website
1000+ mentions
|
RRID:CVCL_0134
|
Homo sapiens (Human)
|
Ovarian endometrioid adenocarcinoma
|
Population: African American., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1348364 PMID:1999494 PMID:2429947 PMID:2751261 PMID:3335022 PMID:3539322 PMID:3986765 PMID:6173755 PMID:6372095 PMID:6954533 PMID:7927910 PMID:8012063 PMID:8557231 PMID:9041185 PMID:11103784 PMID:11416159 PMID:12080474 PMID:15677628 PMID:18273836 PMID:19714814 PMID:20164919 PMID:20204287 PMID:20215515 PMID:22328975 PMID:22460905 PMID:22585861 PMID:22705003 PMID:22710073 PMID:23415752 PMID:23839242 PMID:24023729 PMID:25230021 PMID:25485619 PMID:25846456 PMID:25877200 PMID:25984343 PMID:26589293 PMID:26972028 PMID:27141528 PMID:27235858 PMID:27397505 PMID:27561551 PMID:28196595 PMID:28273451 PMID:28546799 PMID:30485824 PMID:30894224 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:33287223 PMID:34071702 PMID:35839778 PMID:36476833
|
Cancer cell line
|
Female |
A-2780, 2780, A2780S, A2780par |
|
|
BTO:BTO_0002549, CLO:CLO_0001571, EFO:EFO_0006362, MCCL:MCC:0000027, CLDB:cl193, CLDB:cl194, CLDB:cl4894, ABM:T8089, AddexBio:C0017002/20, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BCRJ:0031, BioGRID_ORCS_Cell_line:329, BioSample:SAMN03472806, BioSample:SAMN10988216, cancercelllines:CVCL_0134, CancerTools:152706, Cell_Model_Passport:SIDM00210, ChEMBL-Cells:CHEMBL3308421, ChEMBL-Targets:CHEMBL614004, CLS:300491, Cosmic:688090, Cosmic:755844, Cosmic:849607, Cosmic:906804, Cosmic:923108, Cosmic:948284, Cosmic:987394, Cosmic:1093558, Cosmic:1102819, Cosmic:1139223, Cosmic:1198265, Cosmic:1305309, Cosmic:1609529, Cosmic:1707564, Cosmic:1708387, Cosmic:1709251, Cosmic:1945872, Cosmic:1995331, Cosmic:2582805, Cosmic:2674698, Cosmic-CLP:906804, DepMap:ACH-000657, ECACC:93112519, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:906804, GEO:GSM184388, GEO:GSM184389, GEO:GSM383925, GEO:GSM503257, GEO:GSM659370, GEO:GSM711722, GEO:GSM827312, GEO:GSM851909, GEO:GSM886853, GEO:GSM887918, GEO:GSM1001419, GEO:GSM1001420, GEO:GSM1001488, GEO:GSM1291126, GEO:GSM1291129, GEO:GSM1340577, GEO:GSM1374380, GEO:GSM1374381, GEO:GSM1669581, GEO:GSM2474971, GEO:GSM4845007, GEO:GSM4845008, GEO:GSM6065211, GEO:GSM6065212, GEO:GSM6065213, IARC_TP53:21161, ICLC:HTL98008, LiGeA:CCLE_809, LINCS_LDP:LCL-1518, Lonza:207, MetaboLights:MTBLS156, MetaboLights:MTBLS1014, NCI-DTP:A2780, PharmacoDB:A2780_40_2019, PRIDE:PXD001176, PRIDE:PXD003105, PRIDE:PXD003252, PRIDE:PXD003668, PRIDE:PXD013811, PRIDE:PXD030304, Progenetix:CVCL_0134, PubChem_Cell_line:CVCL_0134, Wikidata:Q54606559, Ximbio:152706 |
|
|
CVCL_0134 |
2026-09-05 11:43:52 |
2271 |
ASH-3
Resource Report
Resource Website
Discontinued
|
RRID:CVCL_2856
|
Homo sapiens (Human)
|
Thyroid gland anaplastic carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:11686581 PMID:20215515 PMID:23833040 PMID:25877200 PMID:27397505 PMID:30737244 PMID:30894373 PMID:35839778
|
Cancer cell line
|
Female |
ASH3 |
|
|
CLO:CLO_0037151, ArrayExpress:E-MTAB-3610, BioSample:SAMN03470933, cancercelllines:CVCL_2856, Cell_Model_Passport:SIDM00491, Cosmic:2054110, Cosmic-CLP:1290722, DepMap:ACH-001443, EGA:EGAS00001000978, GDSC:1290722, GEO:GSM827189, GEO:GSM1669602, JCRB:JCRB1073, JCRB:NIHS0269, LINCS_LDP:LCL-1682, PharmacoDB:ASH3_65_2019, PRIDE:PXD030304, Progenetix:CVCL_2856, Wikidata:Q54750715 |
|
|
CVCL_2856 |
2026-09-05 11:46:48 |
0 |
ALL-PO
Resource Report
Resource Website
|
RRID:CVCL_1069
|
Homo sapiens (Human)
|
Childhood B acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9444945 PMID:14671638 PMID:20164919 PMID:27397505 PMID:30894373 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Female |
ALLPO, AllPO |
|
|
CLO:CLO_0001705, CLDB:cl5399, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, cancercelllines:CVCL_1069, Cell_Model_Passport:SIDM00211, ChEMBL-Cells:CHEMBL3308227, ChEMBL-Targets:CHEMBL2366294, Cosmic:910944, Cosmic-CLP:910944, DepMap:ACH-002209, EGA:EGAS00001000978, GDSC:910944, GEO:GSM1669596, GEO:GSM5137706, GEO:GSM5137750, IARC_TP53:21173, ICLC:HTL01003, LINCS_LDP:LCL-1043, PharmacoDB:ALLPO_58_2019, PRIDE:PXD023662, PRIDE:PXD030304, PubChem_Cell_line:CVCL_1069, Wikidata:Q54749226 |
|
|
CVCL_1069 |
2026-09-05 11:46:32 |
0 |
ALL-SIL
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1805
|
Homo sapiens (Human)
|
Childhood T acute lymphoblastic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8127147 PMID:8641406 PMID:10071127 PMID:10739008 PMID:11226526 PMID:14504097 PMID:15361874 PMID:15472075 PMID:17117183 PMID:22675565 PMID:26589293 PMID:27397505 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35354797 PMID:35839778
|
Cancer cell line
|
Male |
ALLSIL, SIL-ALL, Sil-ALL |
|
|
BTO:BTO_0005360, CLO:CLO_0037168, EFO:EFO_0022414, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473514, BioSample:SAMN10988449, cancercelllines:CVCL_1805, Cell_Model_Passport:SIDM00994, Cosmic:721715, Cosmic:913404, Cosmic:933537, Cosmic:996306, Cosmic:998724, Cosmic:1037687, Cosmic:1115585, Cosmic:1175126, Cosmic:1224372, Cosmic:1330498, Cosmic:1524789, Cosmic:1641391, Cosmic:1664519, Cosmic:1760517, Cosmic:2165718, Cosmic:2602907, Cosmic-CLP:1295740, DepMap:ACH-000105, DSMZ:ACC-511, DSMZCellDive:ACC-511, EGA:EGAS00001000978, GDSC:1295740, GEO:GSM1669597, GEO:GSM5137707, LiGeA:CCLE_156, LINCS_LDP:LCL-2059, PharmacoDB:ALLSIL_59_2019, PRIDE:PXD023662, PRIDE:PXD030304, Progenetix:CVCL_1805, Wikidata:Q54749231 |
|
|
CVCL_1805 |
2026-09-05 11:46:32 |
6 |
AM-38
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1070
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7947440 PMID:8145054 PMID:12068308 PMID:16232199 PMID:20164919 PMID:22460905 PMID:25877200 PMID:25984343 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
AM38, AM |
|
|
CLO:CLO_0009880, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:829, BioSample:SAMN03470932, BioSample:SAMN10987853, cancercelllines:CVCL_1070, Cell_Model_Passport:SIDM00492, CGH-DB:139-1, ChEMBL-Cells:CHEMBL3308829, ChEMBL-Targets:CHEMBL2366192, Cosmic:685873, Cosmic:910933, Cosmic:1746962, Cosmic:2302334, Cosmic:2367507, Cosmic:2516013, Cosmic-CLP:910933, DepMap:ACH-000269, EGA:EGAS00001000978, GDSC:910933, GEO:GSM326247, GEO:GSM886866, GEO:GSM887931, GEO:GSM1669598, IARC_TP53:21174, JCRB:IFO50492, LiGeA:CCLE_669, LINCS_LDP:LCL-1366, PharmacoDB:AM38_60_2019, PRIDE:PXD030304, Progenetix:CVCL_1070, PubChem_Cell_line:CVCL_1070, Wikidata:Q54749551 |
|
|
CVCL_1070 |
2026-09-05 11:46:36 |
7 |
AN3-CA
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_0028
|
Homo sapiens (Human)
|
Acanthosis nigricans
|
Population: Caucasian., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ERK genetic alteration cell panel (ATCC TCP-1033)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080 PMID:3518877 PMID:6220172 PMID:11668190 PMID:14207855 PMID:16957166 PMID:20164919 PMID:20215515 PMID:20218740 PMID:20944090 PMID:22460905 PMID:22710073 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
AN3_CA, AN3 CA, AN3 Ca, AN3CA, AN-3, AN3, Acanthosis Nigricans 3rd attempt-CArcinoma |
|
|
BTO:BTO_0001771, CLO:CLO_0001722, CLO:CLO_0037160, EFO:EFO_0002110, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:HTB-111, BCRJ:0363, BioSample:SAMN03471092, BioSample:SAMN03473131, BioSample:SAMN03473336, BioSample:SAMN10988375, cancercelllines:CVCL_0028, CCRID:4201HUM-CCTCC00127, CCTCC:GDC0127, Cell_Model_Passport:SIDM00901, ChEMBL-Cells:CHEMBL3308708, ChEMBL-Targets:CHEMBL1075392, CLS:300119, Cosmic:687550, Cosmic:699283, Cosmic:713473, Cosmic:713495, Cosmic:809134, Cosmic:846176, Cosmic:871551, Cosmic:889116, Cosmic:910781, Cosmic:980634, Cosmic:1007162, Cosmic:1057760, Cosmic:1066221, Cosmic:1070810, Cosmic:1102376, Cosmic:1105620, Cosmic:1177683, Cosmic:1223484, Cosmic:1434192, Cosmic:1576450, Cosmic:1622894, Cosmic:1696752, Cosmic:2030460, Cosmic:2646618, Cosmic-CLP:910781, DepMap:ACH-000940, DSMZ:ACC-267, DSMZCellDive:ACC-267, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910781, GEO:GSM374970, GEO:GSM375429, GEO:GSM827494, GEO:GSM886869, GEO:GSM887934, GEO:GSM1669600, GEO:GSM3161710, GEO:GSM3161711, GEO:GSM7701431, GEO:GSM7701432, IARC_TP53:21175, IGRhCellID:AN3CA, IZSLER:BS TCL 200, LiGeA:CCLE_574, LINCS_LDP:LCL-1499, PharmacoDB:AN3CA_63_2019, PRIDE:PXD030304, Progenetix:CVCL_0028, PubChem_Cell_line:CVCL_0028, TOKU-E:543, Wikidata:Q54749896 |
|
|
CVCL_0028 |
2026-09-05 11:46:38 |
17 |
AU565
Resource Report
Resource Website
10+ mentions
|
RRID:CVCL_1074
|
Homo sapiens (Human)
|
Breast adenocarcinoma
|
Population: Caucasian., Part of: MET genetic alteration cell panel (ATCC TCP-1036)., Part of: MD Anderson Cell Lines Project., Part of: JWGray breast cancer cell line panel., Part of: ICBP43 breast cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:17157791 PMID:18516279 PMID:20070913 PMID:20164919 PMID:22460905 PMID:24094812 PMID:24176112 PMID:25877200 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:29273624 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:35839778
|
Cancer cell line
|
Female |
AU-565, AU 565 |
|
|
BTO:BTO_0004737, CLO:CLO_0001769, EFO:EFO_0001087, AddexBio:C0006010/4900, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-TABM-157, ArrayExpress:E-TABM-244, ATCC:CRL-2351, BioGRID_ORCS_Cell_line:333, BioSample:SAMN03470878, BioSample:SAMN03471449, BioSample:SAMN10987882, cancercelllines:CVCL_1074, Cell_Model_Passport:SIDM00898, ChEMBL-Cells:CHEMBL3308095, ChEMBL-Targets:CHEMBL1075393, CLS:305313, Cosmic:687462, Cosmic:910704, Cosmic:1136358, Cosmic:1176652, Cosmic:1309002, Cosmic:1995342, Cosmic:2165002, Cosmic-CLP:910704, DepMap:ACH-000248, EGA:EGAS00001000978, GDSC:910704, GEO:GSM274658, GEO:GSM344340, GEO:GSM344390, GEO:GSM843441, GEO:GSM843442, GEO:GSM847196, GEO:GSM847451, GEO:GSM886871, GEO:GSM887936, GEO:GSM1053701, GEO:GSM1172851, GEO:GSM1172939, GEO:GSM1238118, GEO:GSM1421428, GEO:GSM1669605, GEO:GSM2258812, GEO:GSM2258813, GEO:GSM2258814, GEO:GSM2258815, GEO:GSM2258816, GEO:GSM2258817, GEO:GSM2258818, GEO:GSM2258819, GEO:GSM2258820, GEO:GSM2258821, GEO:GSM2258822, GEO:GSM2258823, GEO:GSM2258824, GEO:GSM2258825, GEO:GSM2258826, GEO:GSM2258827, GEO:GSM2258828, GEO:GSM2258829, GEO:GSM2258923, GEO:GSM2258924, GEO:GSM2258925, IARC_TP53:21178, LiGeA:CCLE_052, LINCS_HMS:50091, LINCS_LDP:LCL-1462, PharmacoDB:AU565_70_2019, PRIDE:PXD030304, Progenetix:CVCL_1074, PubChem_Cell_line:CVCL_1074, SLKBase:3384, Wikidata:Q54751885 |
|
|
CVCL_1074 |
2026-09-05 11:47:01 |
33 |
BONNA-12
Resource Report
Resource Website
Possibly Misidentified
|
RRID:CVCL_1090
|
Homo sapiens (Human)
|
Hairy cell leukemia
|
Karyotypic information: Has lost chromosome Y., Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Possibly misidentified. It is not certain that this cell line originate from a hairy cell leukemia (PubMed=22653958)..
|
PMID:1313127 PMID:20164919 PMID:20454443 PMID:22653958 PMID:27397505 PMID:27463354 PMID:29989027 PMID:30894373 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Male |
Bonna-12, BONNA12, Bonna12 |
|
|
CLO:CLO_0002014, CLDB:cl473, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03473418, cancercelllines:CVCL_1090, Cell_Model_Passport:SIDM00984, Cosmic:906695, Cosmic:2690006, Cosmic:2756295, Cosmic-CLP:906695, DepMap:ACH-001452, DSMZ:ACC-150, DSMZCellDive:ACC-150, EGA:EGAS00001000978, GEO:GSM1669627, IARC_TP53:21196, PharmacoDB:BONNA12_106_2019, PRIDE:PXD030304, Wikidata:Q54797948 |
|
|
CVCL_1090 |
2026-09-05 11:50:36 |
0 |
BPH-1
Resource Report
Resource Website
100+ mentions
|
Millipore Cat# SCC256, RRID:CVCL_1091
|
Homo sapiens (Human)
|
Benign prostatic hyperplasia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7535634 PMID:11304728 PMID:11719443 PMID:20164919 PMID:20215515 PMID:21248069 PMID:27397505 PMID:30894373 PMID:35839778
|
Transformed cell line
|
Male |
BPH1, Benign Prostatic Hyperplasia-1 |
Millipore |
SCC256 |
BTO:BTO_0001323, CLO:CLO_0002022, EFO:EFO_0022691, CLDB:cl7219, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473417, cancercelllines:CVCL_1091, Cell_Model_Passport:SIDM00964, ChEMBL-Cells:CHEMBL3308186, ChEMBL-Targets:CHEMBL2366131, Cosmic:924105, Cosmic:1995347, Cosmic-CLP:924105, DepMap:ACH-001453, DSMZ:ACC-143, DSMZCellDive:ACC-143, EGA:EGAS00001000978, GDSC:924105, GEO:GSM827571, GEO:GSM1374405, GEO:GSM1669628, IARC_TP53:27687, ICLC:HTL11006, IGRhCellID:BPH1, LINCS_HMS:50005, LINCS_LDP:LCL-2095, Millipore:SCC256, PharmacoDB:BPH1_107_2019, PRIDE:PXD030304, Progenetix:CVCL_1091, PubChem_Cell_line:CVCL_1091, SKY/M-FISH/CGH:1510, Wikidata:Q54798059 |
|
|
CVCL_1091 |
2026-09-05 11:50:39 |
169 |
BPH-1
Resource Report
Resource Website
100+ mentions
|
RRID:CVCL_1091
|
Homo sapiens (Human)
|
Benign prostatic hyperplasia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7535634 PMID:11304728 PMID:11719443 PMID:20164919 PMID:20215515 PMID:21248069 PMID:27397505 PMID:30894373 PMID:35839778
|
Transformed cell line
|
Male |
BPH1, Benign Prostatic Hyperplasia-1 |
|
|
BTO:BTO_0001323, CLO:CLO_0002022, EFO:EFO_0022691, CLDB:cl7219, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473417, cancercelllines:CVCL_1091, Cell_Model_Passport:SIDM00964, ChEMBL-Cells:CHEMBL3308186, ChEMBL-Targets:CHEMBL2366131, Cosmic:924105, Cosmic:1995347, Cosmic-CLP:924105, DepMap:ACH-001453, DSMZ:ACC-143, DSMZCellDive:ACC-143, EGA:EGAS00001000978, GDSC:924105, GEO:GSM827571, GEO:GSM1374405, GEO:GSM1669628, IARC_TP53:27687, ICLC:HTL11006, IGRhCellID:BPH1, LINCS_HMS:50005, LINCS_LDP:LCL-2095, Millipore:SCC256, PharmacoDB:BPH1_107_2019, PRIDE:PXD030304, Progenetix:CVCL_1091, PubChem_Cell_line:CVCL_1091, SKY/M-FISH/CGH:1510, Wikidata:Q54798059 |
|
|
CVCL_1091 |
2026-09-05 11:50:39 |
169 |
BC-1
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1079
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7670109 PMID:8523568 PMID:9766492 PMID:15613351 PMID:17121789 PMID:20164919 PMID:20215515 PMID:21685375 PMID:27397505 PMID:30894373 PMID:35839778 PMID:36094314
|
Cancer cell line
|
Male |
BC1 |
|
|
BTO:BTO_0002720, CLO:CLO_0001887, EFO:EFO_0002044, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:CRL-2230, BioSample:SAMN03471843, BioSample:SAMN03473432, BioSamples:SAMEA365796, BioSamples:SAMEA365808, cancercelllines:CVCL_1079, Cell_Model_Passport:SIDM00896, ChEMBL-Cells:CHEMBL3307907, ChEMBL-Targets:CHEMBL614277, Cosmic:687602, Cosmic:910919, Cosmic:1515186, Cosmic:1588556, Cosmic-CLP:910919, DepMap:ACH-002214, DSMZ:ACC-677, DSMZCellDive:ACC-677, EGA:EGAS00001000978, GDSC:910919, GEO:GSM33136, GEO:GSM38792, GEO:GSM38793, GEO:GSM634731, GEO:GSM710417, GEO:GSM710433, GEO:GSM1669610, GEO:GSM3150236, IARC_TP53:21189, IARC_TP53:23656, IGRhCellID:BC1, LINCS_LDP:LCL-1956, Lonza:914, PharmacoDB:BC1_77_2019, PRIDE:PXD012087, PRIDE:PXD030304, Progenetix:CVCL_1079, PubChem_Cell_line:CVCL_1079, Wikidata:Q54795185 |
|
|
CVCL_1079 |
2026-09-05 11:50:07 |
5 |
BC-3
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1080
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:8839859 PMID:9766492 PMID:15613351 PMID:17121789 PMID:19608668 PMID:20164919 PMID:20215515 PMID:21685375 PMID:27397505 PMID:30894373 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Male |
BC3 |
|
|
BTO:BTO_0002722, CLO:CLO_0001891, EFO:EFO_0002046, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CRL-2277, ATCC:CRL-3615, BioGRID_ORCS_Cell_line:1098, BioSample:SAMN03472835, BioSamples:SAMEA365848, BioSamples:SAMEA365859, cancercelllines:CVCL_1080, CCRID:3101HUMSCSP5016, CCTCC:GDC0221, Cell_Model_Passport:SIDM00895, ChEMBL-Cells:CHEMBL3308890, ChEMBL-Targets:CHEMBL2366371, Cosmic:687836, Cosmic:910918, Cosmic:1238077, Cosmic:1515188, Cosmic:1588558, Cosmic-CLP:910918, DepMap:ACH-002215, DSMZ:ACC-679, DSMZCellDive:ACC-679, GDSC:910918, GEO:GSM33135, GEO:GSM38796, GEO:GSM38797, GEO:GSM634733, GEO:GSM710419, GEO:GSM710435, GEO:GSM1669611, GEO:GSM3150237, IARC_TP53:21190, IARC_TP53:26979, IGRhCellID:BC3, LINCS_LDP:LCL-1948, PharmacoDB:BC3_79_2019, PRIDE:PXD012087, PRIDE:PXD030304, Progenetix:CVCL_1080, PubChem_Cell_line:CVCL_1080, Wikidata:Q54795189 |
|
|
CVCL_1080 |
2026-09-05 11:50:07 |
8 |
BC-1
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-677, RRID:CVCL_1079
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7670109 PMID:8523568 PMID:9766492 PMID:15613351 PMID:17121789 PMID:20164919 PMID:20215515 PMID:21685375 PMID:27397505 PMID:30894373 PMID:35839778 PMID:36094314
|
Cancer cell line
|
Male |
BC1 |
DSMZ |
ACC-677 |
BTO:BTO_0002720, CLO:CLO_0001887, EFO:EFO_0002044, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:CRL-2230, BioSample:SAMN03471843, BioSample:SAMN03473432, BioSamples:SAMEA365796, BioSamples:SAMEA365808, cancercelllines:CVCL_1079, Cell_Model_Passport:SIDM00896, ChEMBL-Cells:CHEMBL3307907, ChEMBL-Targets:CHEMBL614277, Cosmic:687602, Cosmic:910919, Cosmic:1515186, Cosmic:1588556, Cosmic-CLP:910919, DepMap:ACH-002214, DSMZ:ACC-677, DSMZCellDive:ACC-677, EGA:EGAS00001000978, GDSC:910919, GEO:GSM33136, GEO:GSM38792, GEO:GSM38793, GEO:GSM634731, GEO:GSM710417, GEO:GSM710433, GEO:GSM1669610, GEO:GSM3150236, IARC_TP53:21189, IARC_TP53:23656, IGRhCellID:BC1, LINCS_LDP:LCL-1956, Lonza:914, PharmacoDB:BC1_77_2019, PRIDE:PXD012087, PRIDE:PXD030304, Progenetix:CVCL_1079, PubChem_Cell_line:CVCL_1079, Wikidata:Q54795185 |
|
|
CVCL_1079 |
2026-09-05 11:50:07 |
5 |
BC-1
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-2230, RRID:CVCL_1079
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7670109 PMID:8523568 PMID:9766492 PMID:15613351 PMID:17121789 PMID:20164919 PMID:20215515 PMID:21685375 PMID:27397505 PMID:30894373 PMID:35839778 PMID:36094314
|
Cancer cell line
|
Male |
BC1 |
ATCC |
CRL-2230 |
BTO:BTO_0002720, CLO:CLO_0001887, EFO:EFO_0002044, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ATCC:CRL-2230, BioSample:SAMN03471843, BioSample:SAMN03473432, BioSamples:SAMEA365796, BioSamples:SAMEA365808, cancercelllines:CVCL_1079, Cell_Model_Passport:SIDM00896, ChEMBL-Cells:CHEMBL3307907, ChEMBL-Targets:CHEMBL614277, Cosmic:687602, Cosmic:910919, Cosmic:1515186, Cosmic:1588556, Cosmic-CLP:910919, DepMap:ACH-002214, DSMZ:ACC-677, DSMZCellDive:ACC-677, EGA:EGAS00001000978, GDSC:910919, GEO:GSM33136, GEO:GSM38792, GEO:GSM38793, GEO:GSM634731, GEO:GSM710417, GEO:GSM710433, GEO:GSM1669610, GEO:GSM3150236, IARC_TP53:21189, IARC_TP53:23656, IGRhCellID:BC1, LINCS_LDP:LCL-1956, Lonza:914, PharmacoDB:BC1_77_2019, PRIDE:PXD012087, PRIDE:PXD030304, Progenetix:CVCL_1079, PubChem_Cell_line:CVCL_1079, Wikidata:Q54795185 |
|
|
CVCL_1079 |
2026-09-05 11:50:07 |
5 |
BFTC-905
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1083
|
Homo sapiens (Human)
|
Bladder carcinoma
|
Population: Chinese; Taiwan., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8712703 PMID:15846775 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24035680 PMID:24367658 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:29732388 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Female |
BFTC 905, BFTC905, Black Foot disease Transitional Carcinoma 905 |
|
|
CLO:CLO_0001948, EFO:EFO_0002115, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BCRC:60068, BioGRID_ORCS_Cell_line:507, BioSample:SAMN03471907, BioSample:SAMN10988546, cancercelllines:CVCL_1083, Cell_Model_Passport:SIDM00989, ChEMBL-Cells:CHEMBL3308470, ChEMBL-Targets:CHEMBL1075396, Cosmic:910926, Cosmic:1046686, Cosmic:1285113, Cosmic:1286006, Cosmic:2050438, Cosmic:2057443, Cosmic:2444237, Cosmic:2685939, Cosmic-CLP:910926, DepMap:ACH-000802, DSMZ:ACC-361, DSMZCellDive:ACC-361, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:910926, GEO:GSM827159, GEO:GSM886879, GEO:GSM887944, GEO:GSM1374403, GEO:GSM1669617, IARC_TP53:21182, IGRhCellID:BFTC905, LiGeA:CCLE_190, LINCS_LDP:LCL-1710, PharmacoDB:BFTC905_88_2019, PRIDE:PXD030304, Progenetix:CVCL_1083, PubChem_Cell_line:CVCL_1083, Wikidata:Q54796201 |
|
|
CVCL_1083 |
2026-09-05 11:50:16 |
3 |
BICR 78
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2315
|
Homo sapiens (Human)
|
Alveolar ridge squamous cell carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7646764 PMID:9150362 PMID:10523844 PMID:20215515 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:35839778
|
Cancer cell line
|
Male |
BICR-78, BICR78, Beatson Institute for Cancer Research 78 |
|
|
CLO:CLO_0009944, EFO:EFO_0006543, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:837, BioSample:SAMN03473146, cancercelllines:CVCL_2315, CancerTools:152849, Cell_Model_Passport:SIDM00501, Cosmic:848755, Cosmic:1995346, Cosmic-CLP:1240122, DepMap:ACH-001332, ECACC:04072111, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1240122, GEO:GSM827457, GEO:GSM1669624, LINCS_LDP:LCL-1205, PharmacoDB:BICR78_100_2019, PRIDE:PXD030304, Progenetix:CVCL_2315, Wikidata:Q54796540, Ximbio:152849 |
|
|
CVCL_2315 |
2026-09-05 11:50:20 |
2 |
BHY
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1086
|
Homo sapiens (Human)
|
Alveolar ridge squamous cell carcinoma
|
Population: Japanese., Part of: OPC-22 oral and pharyngeal cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:8985100 PMID:15800904 PMID:17390010 PMID:17719389 PMID:18423281 PMID:20164919 PMID:20215515 PMID:22460905 PMID:25275298 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
|
|
|
BTO:BTO_0004588, CLO:CLO_0001975, EFO:EFO_0006539, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:334, BioSample:SAMN03473142, BioSample:SAMN10987691, cancercelllines:CVCL_1086, Cell_Model_Passport:SIDM00986, ChEMBL-Cells:CHEMBL3308711, ChEMBL-Targets:CHEMBL1075399, Cosmic:753535, Cosmic:2296290, Cosmic-CLP:753535, DepMap:ACH-000548, DSMZ:ACC-404, DSMZCellDive:ACC-404, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:753535, GEO:GSM886882, GEO:GSM887947, GEO:GSM1669620, IARC_TP53:25036, LiGeA:CCLE_194, LINCS_LDP:LCL-1208, NCBI_Iran:C622, PharmacoDB:BHY_92_2019, PRIDE:PXD030304, Progenetix:CVCL_1086, PubChem_Cell_line:CVCL_1086, Wikidata:Q54796512 |
|
|
CVCL_1086 |
2026-09-05 11:50:20 |
4 |
BL-41
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1087
|
Homo sapiens (Human)
|
Burkitt lymphoma
|
Virology: EBV-negative., Population: Caucasian., From: International Agency of Research on Cancer (IARC); Lyon; France., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1915267 PMID:2645221 PMID:2825176 PMID:3026973 PMID:3027441 PMID:3037521 PMID:3905596 PMID:3934070 PMID:6592381 PMID:8547074 PMID:8558920 PMID:9192833 PMID:9473234 PMID:9973220 PMID:11793449 PMID:16960149 PMID:19358282 PMID:20164919 PMID:22460905 PMID:22885699 PMID:24590883 PMID:25355872 PMID:25960936 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:35839778
|
Cancer cell line
|
Male |
BL41, BL 41, BL 041, IARC/BL41, IARC/BL 41, IARC-BL41, IARC BL41, IARC-BL-41, IARC BL 41 |
|
|
BTO:BTO_0003854, CLO:CLO_0001987, EFO:EFO_0022580, CLDB:cl459, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioSample:SAMN03473420, BioSample:SAMN10987706, cancercelllines:CVCL_1087, Cell_Model_Passport:SIDM00985, ChEMBL-Cells:CHEMBL3308526, ChEMBL-Targets:CHEMBL2366173, Cosmic:910706, Cosmic:931099, Cosmic:991550, Cosmic:1086324, Cosmic:1818339, Cosmic:2297031, Cosmic:2361383, Cosmic:2814533, Cosmic-CLP:910706, DepMap:ACH-000245, DSMZ:ACC-160, DSMZCellDive:ACC-160, EGA:EGAS00001000978, GDSC:910706, GEO:GSM119535, GEO:GSM862863, GEO:GSM862864, GEO:GSM862865, GEO:GSM862866, GEO:GSM886889, GEO:GSM887954, GEO:GSM1669625, GEO:GSM3150241, IARC_TP53:700, IARC_TP53:21194, LiGeA:CCLE_122, LINCS_LDP:LCL-2028, NCBI_Iran:C493, PharmacoDB:BL41_103_2019, PRIDE:PXD012087, PRIDE:PXD030304, Progenetix:CVCL_1087, PubChem_Cell_line:CVCL_1087, Wikidata:Q54797155 |
|
|
CVCL_1087 |
2026-09-05 11:50:27 |
5 |
HeLa
Resource Report
Resource Website
10000+ mentions
Discontinued
|
Hysigen Cat# TCH-C193, RRID:CVCL_0030
|
Homo sapiens (Human)
|
Human papillomavirus-related endocervical adenocarcinoma
|
Miscellaneous: HeLa is the most frequent contributor to cell lines contamination., Anecdotal: Was flown since the 1960s on at least ten different space missions: Korabl-Sputnik-2, Vostok-1, Vostok-4, Vostok-5 and Vostok-6, Voshkod 1 and Zond-5, Discoverer XVIII, Progress M-35/Mir and Shuttle STS-89., Anecdotal: The HeLa cell line and its story inspired Australian artist Cynthia Verspaget to embark in 2003 on a artistic project 'The Anarchy Cell Line' (TAnCL) where she mixed her blood with HeLa cells. This work later spawned a PhD thesis (CelloPub=CLPUB00376) where among other things she makes the observation that two main taxonomical distinctions present in the zombie, living/dead and human/nonhuman, are also present in the HeLa cell line., Anecdotal: The fascinating story of the HeLa cell line and of Henrietta Lacks from whom these cells originate are described in the book of Rebecca Skloot (CelloPub=CLPUB00377)., Anecdotal: The HeLa cell line which was established in February 1951 is the oldest human immortal cell line., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Virology: HeLa has 5 five HPV18 integration sites: three on normal chromosomes 8 at 8q24 and two on derivative chromosomes, der(5)t(5;22;8)(q11;q11q13;q24) and der(22)t(8;22) (q24;q13)., Population: African American., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: MD Anderson Cell Lines Project., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:77569 PMID:1246620 PMID:1522048 PMID:2983228 PMID:2990217 PMID:3028716 PMID:3180844 PMID:3371749 PMID:3518877 PMID:4942173 PMID:5668122 PMID:6256643 PMID:6358339 PMID:6401685 PMID:6825208 PMID:6935474 PMID:8380785 PMID:9892199 PMID:10423141 PMID:11416159 PMID:11668190 PMID:12001993 PMID:12661003 PMID:12793746 PMID:13052828 PMID:13207312 PMID:13261081 PMID:14031339 PMID:14185313 PMID:15302935 PMID:15531914 PMID:15901131 PMID:16589695 PMID:16957166 PMID:17311676 PMID:19450234 PMID:19722756 PMID:19941903 PMID:21269460 PMID:21937730 PMID:22068331 PMID:22278370 PMID:22412903 PMID:23205564 PMID:23336012 PMID:23925224 PMID:23925245 PMID:24134916 PMID:24618588 PMID:24696503 PMID:24908793 PMID:25485619 PMID:25807930 PMID:25877200 PMID:25894527 PMID:25960936 PMID:26554430 PMID:26589293 PMID:27397505 PMID:28078501 PMID:28196595 PMID:28261610 PMID:28601559 PMID:29156801 PMID:30175587 PMID:30778230 PMID:30787054 PMID:30894373 PMID:31068700 PMID:31433507 PMID:31790455 PMID:33389257 PMID:35198691 PMID:35839778 PMID:37543987
|
Cancer cell line
|
Female |
HELA, Hela, He La, He-La, HeLa-CCL2, Henrietta Lacks cells, Helacyton gartleri |
Hysigen |
TCH-C193 |
BTO:BTO_0000567, CLO:CLO_0003684, CLO:CLO_0050910, EFO:EFO_0001185, MCCL:MCC:0000219, CLDB:cl1594, CLDB:cl1595, CLDB:cl1596, CLDB:cl1597, CLDB:cl1599, CLDB:cl1600, CLDB:cl1601, CLDB:cl1603, Abcam:ab255448, Abcam:ab255928, Abcam:ab260075, Abcam:ab271142, Abcam:ab275466, AddexBio:C0008001/44, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, ATCC:CCL-2, ATCC:CRL-7923, ATCC:CRM-CCL-2, BCRC:60005, BCRJ:0100, BEI_Resources:ARP-153, BioGRID_ORCS_Cell_line:95, BioSample:SAMN03471148, BioSample:SAMN03472333, BioSample:SAMN10989629, cancercelllines:CVCL_0030, CCLV:CCLV-RIE 0082, CCRID:1101HUM-PUMC000011, CCRID:1101HUM-PUMC000332, CCRID:1102HUM-NIFDC00057, CCRID:3101HUMSCSP504, CCRID:3101HUMTCHu187, CCRID:4201HUM-CCTCC00009, CCRID:5301HUM-KCB90024YJ, CCTCC:GDC0009, Cell_Model_Passport:SIDM00846, ChEMBL-Cells:CHEMBL3308376, ChEMBL-Targets:CHEMBL399, CLS:300194, Cosmic:760219, Cosmic:760490, Cosmic:801357, Cosmic:809231, Cosmic:877477, Cosmic:911999, Cosmic:925354, Cosmic:928907, Cosmic:944113, Cosmic:1019309, Cosmic:1057766, Cosmic:1071911, Cosmic:1131525, Cosmic:1193029, Cosmic:1201779, Cosmic:1324208, Cosmic:1336880, Cosmic:1571796, Cosmic:2301539, Cosmic:2660190, Cosmic:2750874, Cosmic:2791019, Cosmic:2816214, Cosmic-CLP:1298134, dbGAP:phs000640.v4.p1, DepMap:ACH-001086, DSMZ:ACC-57, DSMZCellDive:ACC-57, ECACC:93021013, EGA:EGAS00001000610, EGA:EGAS00001000978, EGA:phs000640, FCS-free:44-2-47-1-8-9, GDSC:1298134, GEO:GSM113863, GEO:GSM226739, GEO:GSM226875, GEO:GSM253298, GEO:GSM436128, GEO:GSM436129, GEO:GSM501788, GEO:GSM722574, GEO:GSM722575, GEO:GSM723055, GEO:GSM723056, GEO:GSM1088663, GEO:GSM1088664, GEO:GSM1088665, GEO:GSM1088666, GEO:GSM1374528, GEO:GSM1669875, GEO:GSM1881473, GEO:GSM1881474, GEO:GSM1881475, GEO:GSM7701367, GEO:GSM7701368, Hysigen:TCH-C193, ICLC:HTL95023, IGRhCellID:HeLA, IZSLER:BS TCL 20, JCRB:JCRB9004, KCB:KCB 86019YJ, KCB:KCB 90024YJ, KCLB:10002, LINCS_HMS:50061, LINCS_LDP:LCL-1512, Lonza:51, MeSH:D006367, NCBI_Iran:C115, PharmacoDB:HeLa_536_2019, PRIDE:PRD000007, PRIDE:PRD000032, PRIDE:PRD000123, PRIDE:PRD000124, PRIDE:PRD000345, PRIDE:PRD000376, PRIDE:PRD000525, PRIDE:PRD000526, PRIDE:PRD000527, PRIDE:PXD000013, PRIDE:PXD000243, PRIDE:PXD000252, PRIDE:PXD000279, PRIDE:PXD000396, PRIDE:PXD000474, PRIDE:PXD000589, PRIDE:PXD000661, PRIDE:PXD000680, PRIDE:PXD000759, PRIDE:PXD000883, PRIDE:PXD000895, PRIDE:PXD000900, PRIDE:PXD000953, PRIDE:PXD000954, PRIDE:PXD000999, PRIDE:PXD001047, PRIDE:PXD001118, PRIDE:PXD001154, PRIDE:PXD001175, PRIDE:PXD001249, PRIDE:PXD001258, PRIDE:PXD001259, PRIDE:PXD001278, PRIDE:PXD001305, PRIDE:PXD001374, PRIDE:PXD001381, PRIDE:PXD001396, PRIDE:PXD001441, PRIDE:PXD001541, PRIDE:PXD001548, PRIDE:PXD001574, PRIDE:PXD001660, PRIDE:PXD001781, PRIDE:PXD001798, PRIDE:PXD001805, PRIDE:PXD001806, PRIDE:PXD001810, PRIDE:PXD001863, PRIDE:PXD001907, PRIDE:PXD002001, PRIDE:PXD002039, PRIDE:PXD002066, PRIDE:PXD002252, PRIDE:PXD002277, PRIDE:PXD002378, PRIDE:PXD002383, PRIDE:PXD002395, PRIDE:PXD002572, PRIDE:PXD002591, PRIDE:PXD002704, PRIDE:PXD002844, PRIDE:PXD002880, PRIDE:PXD003186, PRIDE:PXD003209, PRIDE:PXD003258, PRIDE:PXD003370, PRIDE:PXD003503, PRIDE:PXD003530, PRIDE:PXD003560, PRIDE:PXD003792, PRIDE:PXD003813, PRIDE:PXD003909, PRIDE:PXD003913, PRIDE:PXD003917, PRIDE:PXD003924, PRIDE:PXD004182, PRIDE:PXD004271, PRIDE:PXD004273, PRIDE:PXD004452, PRIDE:PXD004613, PRIDE:PXD004736, PRIDE:PXD004900, PRIDE:PXD004914, PRIDE:PXD004933, PRIDE:PXD004934, PRIDE:PXD004940, PRIDE:PXD004995, PRIDE:PXD005018, PRIDE:PXD005107, PRIDE:PXD005181, PRIDE:PXD005346, PRIDE:PXD005349, PRIDE:PXD005366, PRIDE:PXD005466, PRIDE:PXD005509, PRIDE:PXD005572, PRIDE:PXD005712, PRIDE:PXD005955, PRIDE:PXD006112, PRIDE:PXD006293, PRIDE:PXD012045, PRIDE:PXD012188, PRIDE:PXD013064, PRIDE:PXD023271, PRIDE:PXD023835, PRIDE:PXD027504, PRIDE:PXD029773, PRIDE:PXD030304, Progenetix:CVCL_0030, PubChem_Cell_line:CVCL_0030, RCB:RCB0007, RCB:RCB3680, SKY/M-FISH/CGH:5351, TKG:TKG 0331, TOKU-E:1434, Ubigene:YC-A012, Wikidata:Q847482 |
|
|
CVCL_0030 |
2026-09-05 11:52:49 |
39236 |
CRO-AP2
Resource Report
Resource Website
1+ mentions
|
DSMZ Cat# ACC-48, RRID:CVCL_1147
|
Homo sapiens (Human)
|
Primary effusion lymphoma
|
Population: Caucasian., Part of: LL-100 blood cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9389573 PMID:9766492 PMID:10784388 PMID:20164919 PMID:20215515 PMID:20454443 PMID:21685375 PMID:27397505 PMID:30894373 PMID:31160637 PMID:35839778
|
Cancer cell line
|
Male |
CRO-AP/2, CROAP2, AP2 |
DSMZ |
ACC-48 |
BTO:BTO_0002724, CLO:CLO_0002617, EFO:EFO_0002145, CLDB:cl3486, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN03473560, cancercelllines:CVCL_1147, Cell_Model_Passport:SIDM00952, ChEMBL-Cells:CHEMBL3308254, ChEMBL-Targets:CHEMBL2366080, Cosmic:906807, Cosmic-CLP:906807, DepMap:ACH-002220, DSMZ:ACC-48, DSMZCellDive:ACC-48, EGA:EGAS00001000978, GDSC:906807, GEO:GSM634729, GEO:GSM1669709, IARC_TP53:21257, IGRhCellID:CROAP2, PharmacoDB:CROAP2_264_2019, PRIDE:PXD030304, Progenetix:CVCL_1147, PubChem_Cell_line:CVCL_1147, Wikidata:Q54814506 |
|
|
CVCL_1147 |
2026-09-05 10:46:50 |
1 |